Accretion Pharmaceuticals Limited

₹210.00As of Sun 8 Nov 2026, 12:00 UTC
NSE:ACCPLHealthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE 23.96%
Pharmaceutical Preparations
Beta (5Y) —
PE TTM 17.78
TSR TTM 250.58%
Mkt cap ₹2.334B
ROIC 17.93%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹215
2.31%
(59.00%)
Hold 2|9|1|2|5
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
3.13
3.45
3.63
4.01
35.01%
42.38%
40.16%
41.54%
Revenue₹M
152.9
161.9
167.9
162.9
5.88%
11.59%
17.63%
7.67%
Peers (US$23.97M)
Cap (US$)
PE
24.71M
44.25x
23.28M
12.14x
Capital
TTM
5Y
10Y
Leveragex
0.953
0.047
0.041
EBIT/Intx
1.603
1.529
1.136
Own earn%
271.60
(27.49)
(13.51)
Sh yield%
37.76
29.09
29.17
Owners
Insiders/Inst%
8.22
75.11
Short interest%
1.33
SBC / revenue%
3.19
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
11
Op margin range%
16–26
$1 testx
—
Incr. ROIC%
42